Navigation Links
New Lawsuit on Avodart Prostate Cancer: Now, AttorneyOne Can Provide Advice

San Diego, CA (PRWEB) December 31, 2012, a recognized authority on law, updated the website recently and is now actively providing expert opinion in view of the recent news on Avodart lawsuits.

According to court documents, on December 6th, 2012, a Texas resident and his wife filed an Avodart Lawsuit in Pennsylvania Eastern District Court (case no. 2:2012cv06818) alleging he developed prostate cancer from his use of the drug Avodart. Avodart (dutasteride), manufactured by GlaxoSmithKline, was approved by the FDA in October 2002 to treat the symptoms of an enlarged prostate gland (benign prostatic hyperplasia or BPH). It is also approved to reduce the risk of urinary retention or surgery related to an enlarged prostate.

Avodart belongs to a class of drugs known as 5-alpha reductase inhibitors (5-ARI). In June 2011, the US FDA issued a warning that 5 alpha-reductase inhibitors (including Avodart) may increase the risk of development of high-grade prostate cancer. And in June 2012, the FDA informed “prior to initiating treatment with Avodart, consideration should be given to other urological conditions that may cause similar symptoms. In addition, BPH and prostate cancer may coexist.”

Taking into consideration the latest developments, updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Avodart severe complications. Sean Burke, director of Media Relations for, adds that the relevant information illustrates that people continue to file Avodart lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On March 19th, 2012 Health Canada issued a warning that Avodart, and other drugs used to treat enlarged prostate, may be associated with an increased risk of developing a serious form of prostate cancer known as high-grade prostate cancer. has further information on Avodart lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website You can also find us on Facebook at Checkout earlier news from us at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Propecia Lawsuits Being Investigated by Bernstein Liebhard LLP, as Propecia Litigation Pending in New Jersey Superior Court Continues to Move Forward
2. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
3. Warning Claim on Alleged Defective Wright Hip Implant Lawsuit Dismissed: AttorneyOne Informs
4. Nexium MDL Consolidated for Bone Fracture Lawsuits: AttorneyOne Informs
5. DrugRisk Announces Updated Information on Mirena Lawsuits
6. Wright & Schulte LLC Files Transvaginal Mesh Lawsuit on Behalf of Woman Allegedly Injured by Align Urethral Support System
7. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
8. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
9. Wright & Schulte File Skechers Lawsuit on Behalf of Ohio Woman Who Fell, Suffered Broken Wrist Allegedly Due to Use of Skechers Shape-Ups
10. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
11. New Lawsuit alleges Actos caused Bladder Cancer
Post Your Comments:
(Date:11/28/2015)... ... , ... Safe storage for contraceptive devices may not always be easy to ... and the other from Bradley Beach, New Jersey, there is an easy solution to ... to replace NuvaRings more often than necessary. As such, it affords peace of mind ...
(Date:11/27/2015)... ... November 28, 2015 , ... There is only one major question facing ... last year? , This question has not been an easy question to answer. Especially ... age and the younger workforce don’t share the same discipline around working long hours. ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion that ... of their purchase of lice treatment product. In addition, customers will receive a complimentary ... spokesperson. “Finding lice is a sure way to ruin the holidays, so we encourage ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... of progress through sharing, the 2016 Building Better Radiology Marketing Programs ... will begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
Breaking Medicine Technology: